Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Kawai; Megumi
Address:
Libertyville, IL
No. of patents:
23
Patents:












Patent Number Title Of Patent Date Issued
7772231 Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors August 10, 2010
Compounds of formula (25) that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. ##STR00001##
7491718 Sulfonamides having antiangiogenic and anticancer activity February 17, 2009
Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
7030262 3-Amino-2-hydroxyalkanoic acids and their prodrugs April 18, 2006
Compounds having the formula ##STR00001## are useful for treating conditions which arise from or are exacerbated by angiogenesis. Also disclosed are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, a
6887863 Hydrazide and alkoxyamide angiogenesis inhibitors May 3, 2005
Compounds having the formula ##STR1##are methionine aminopeptidase type 2 (MetAP2) inhibitors and are useful for inhibiting angiogenesis. Also disclosed are MetAP2-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.
6849757 Antiangiogenic drug to treat cancer, arthritis and retinopathy February 1, 2005
Compounds having Formula I ##STR1##or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to me
6632961 Antiangiogenic drug to treat cancer, arthritis and retinopathy October 14, 2003
Compounds having Formula I ##STR1##or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to me
6323228 3-substituted indole angiogenesis inhibitors November 27, 2001
3-Substituted indole carbohydrazides having the formula ##STR1##are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.
6242494 Substituted .beta.-amino acid inhibitors of methionine aminopeptidase-2 June 5, 2001
A class of substituted b-amino acids are potent inhibitor of methionine aminopeptidase type 2 (MetAP2) and are thus useful in inhibiting angiogenesis and disease conditions which depend upon angiogenesis for their development such as diabetic retinopathy, tumor growth, and conditions
6121257 Sulfamate containing macrocyclic immunomodulators September 19, 2000
The present invention relates to novel compounds of formula I: ##STR1## which are useful as immunomodulators, in particular, macrolide immunosuppressants. The invention also relates to the preparation of compounds of formula I, compositions containing such compounds, and methods
5708002 Macrocyclic immunomodulators January 13, 1998
Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is selected from one of the formulae ##STR2## as well as pharmaceutical compositions containing the same.
5604294 Macrocyclic immunomodulators February 18, 1997
Immunomodulatory macrocyclic compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein Y is selected from one of the formulae ##STR2## as well as pharmaceutical compositions containing the same and methods of
5561228 Macrocyclic immunomodulators October 1, 1996
Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is a group having the formula ##STR2## as well as pharmaceutical compositions containing the same.
5561140 Substituted alicyclic amine-containing macrocyclic immunomodulators October 1, 1996
Compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a group having the formula ##STR2## as well as pharmaceutically co
5561139 Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators October 1, 1996
Compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a radical having the formula ##STR2## as well as pharmaceutica
5541193 Heterocycle-containing macrocyclic immunomodulators July 30, 1996
Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.107, R.sup.108, R.sup.109 and R.sup.110 is a radical having the formula ##STR2## as well as pharmaceutically com
5541189 Substituted aliphatic amine-containing macrocyclic immunomodulators July 30, 1996
Compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a radical having the formula ##STR2## as well as pharmaceutica
5530120 Substituted alicyclic aliphatic-amine containing macrocyclic immunomodulators June 25, 1996
Compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a radical having the formula ##STR2## as well as pharmaceutica
5530119 Substituted alicyclic amine-containing macrocyclic immunomodulators June 25, 1996
Compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a group having the formula ##STR2## as well as pharmaceutically co
5457111 Macrocyclic immunomodulators October 10, 1995
Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is selected from one of the formulae ##STR2## as well as pharmaceutical compositions containing the same.
5387671 Hexa- and heptapeptide anaphylatoxin-receptor ligands February 7, 1995
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states.Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating a
5386011 Hexapeptide anaphylatoxin-receptor ligands January 31, 1995
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states.Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating a
5223485 Anaphylatoxin-receptor ligands June 29, 1993
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q-T are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulatin
5190922 Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands March 2, 1993
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating










 
 
  Recently Added Patents
Managing job execution
Method and apparatus for sensing an input object relative to a sensing region of an ultrasound sensor device
Apparatus and method for image encoding/decoding using predictability of intra-prediction mode
In-vehicle electronic control apparatus having monitoring control circuit
Deposited conductive layers for leads of implantable electric stimulation systems and methods of making and using
Vehicle tail lamp
System, method, and software for researching, analyzing and comparing expert witnesses
  Randomly Featured Patents
Pressure washer with vibration dampener
Table lamp
Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
Universal authentication mechanism
Composite textile material capable of being employed for resin reinforcement
Bolt-lock structure
Method of making battered and breaded food compositions using calcium pectins
Packet switch realizing transmission with no packet delay
Edge-lighted display
Apparatus for repairing and straightening vehicles